Neuberger Berman High Yield Strategies Fund Announces $7.44/share Purchase

Neuberger Berman High Yield Strategies Fund Inc. (NHS) has recently disclosed that Christopher Kocinski has made a significant investment in the company. On May 29, 2025, Kocinski acquired 15,000 shares at a per-share price of $7.44.

On May 29, 2025, Christopher Kocinski, a director and portfolio manager at Neuberger Berman Investment Advisers LLC, acquired 15,000 shares of Neuberger Berman High Yield Strategies Fund Inc. (NHS) at a per-share price of $7.44 [1]. This transaction was disclosed in a Form 4 filing with the U.S. Securities and Exchange Commission (SEC).

NHS is a closed-ended fixed income mutual fund that invests in high yield debt securities across various sectors, including auto parts and equipment, airlines, automotive, electronics, health services, packaging, telecom-integrated/services, gaming, and gas distribution. The fund, managed by Neuberger Berman Investment Advisers LLC, was launched on July 28, 2003 [3].

The acquisition of shares by Kocinski, who is a key figure in the fund's management, indicates a level of confidence in the fund's prospects. This aligns with the broader trend of insider buying, as seen in other recent transactions involving high-profile insiders such as Jeffrey Yurcisin, President & CEO of Grove Collaborative Holdings Inc., who purchased 15,000 shares of his company on May 23, 2025 [2].

The stock's recent performance has been mixed, with shares crossing below their 200-day moving average on May 28, 2025. However, the fund's dividend policy remains attractive, with a monthly dividend of $0.0905, representing a $1.09 annualized dividend and a dividend yield of 14.72% [4]. This suggests that the fund continues to offer a compelling investment proposition despite recent market fluctuations.

References:
[1] https://www.streetinsider.com/SEC+Filings/Form+4+Neuberger+Berman+High+For%3A+May+29+Filed+by%3A+Kocinski+Chris/24879207.html
[2] https://www.gurufocus.com/news/2890394/insider-buying-jeffrey-yurcisin-acquires-15000-shares-of-grove-collaborative-holdings-inc-grov
[3] https://finance.yahoo.com/quote/NHS/
[4] https://www.marketbeat.com/instant-alerts/neuberger-berman-high-yield-strategies-fund-nyseamericannhs-shares-pass-below-200-day-moving-average-heres-what-happened-2025-05-28/